Results 21 to 30 of about 41,522 (262)
Oral health status of asthmatic children using inhaled corticosteroids
The Turkish Journal of Pediatrics, 2021 Background. Due to the increase in the prevalence of asthma, especially in childhood, oral health problems arising from the use of asthma medications have become a major health concern.
Münevver Doğan +5 more
doaj +1 more source
Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma [PDF]
Tuberculosis and Respiratory Diseases, 2023 The introduction of inhaled corticosteroids (ICS) for the management of asthma has led to a decrease in acute exacerbation of asthma. However, there are concerns regarding the safety of long-term ICS use, particularly pneumonia.
Ye Jin Lee, Yong-Bum Park
doaj +1 more source
Inhaled corticosteroids for cystic fibrosis [PDF]
, 2000 Maintenance of optimal lung function is an important therapeutic goal in cystic fibrosis as it is lung damage that, in the long term, is responsible for most premature death among affected people. Inhaled corticosteroids are being increasingly used to treat children and adults with cystic fibrosis.
C, Dezateux, S, Walters, I, Balfour-Lynn
openaire +2 more sources
Inhaled Corticosteroids in Lung Diseases [PDF]
American Journal of Respiratory and Critical Care Medicine, 2013 Abstract Inhaled corticosteroids (ICSs) are used extensively in the treatment of asthma and chronic obstructive pulmonary disease (COPD) due to their broad antiinflammatory effects. They improve lung function, symptoms, and quality of life and reduce exacerbations in both conditions but do not alter the progression of disease.
Hengameh H, Raissy +3 more
openaire +2 more sources
Idiopathic intracranial hypertension as a presenting sign of adrenal insufficiency
SAGE Open Medical Case Reports, 2018 Idiopathic intracranial hypertension is a diagnosis of exclusion defined by elevated intracranial pressure without mass lesions or hydrocephalus.
Sandra Shenouda +3 more
doaj +1 more source
Inhaled corticosteroids in COPD
The European respiratory journal, 2018 The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can result in clear clinical benefits in some patients (“friend”) but can be ineffective or even associated with undesired side effects, e.g. pneumonia, in others (“foe”).
Agusti, Alvar +7 more
openaire +2 more sources
A simple prediction tool for inhaled corticosteroid response in asthmatic children
BMC Pulmonary Medicine, 2017 Background Inhaled corticosteroids are recommended as the first-line controller medication for childhood asthma owing to their multiple clinical benefits.
Yi-Fan Wu +5 more
doaj +1 more source
Advanced Science, EarlyView.A nebulized nanoassembly alleviates radiation‐induced lung injury by reprogramming macrophages through coordinated ROS scavenging, NAD+ replenishment, and PPAR‐γ activation. Redox balance, mitochondrial homeostasis, and immune regulation are restored, revealing a microenvironment‐centered strategy for localized radioprotection.
Mingquan Gao +11 more
wiley +1 more source
BMC Pulmonary Medicine, 2005 Background There is considerable evidence from the literature that children with chronic lung disease of infancy (CLD) have abnormal pulmonary function in childhood and this could have an impact on their life quality and overall health.
Sauve Reginald +4 more
doaj +1 more source
BMC Pulmonary Medicine, 2023 Background The fracture risk of patients with chronic obstructive pulmonary disease (COPD) treated with inhaled corticosteroids is controversial. And some large-scale randomized controlled trials have not solved this problem.
Shisheng Peng +5 more
doaj +1 more source